Insights to Cure Disease and Heal Healthcare
Understand the power of causal machine learning and why it’s different than other AI solutions for driving precision medicine and discovering what works for whom.
GNS Healthcare applies its groundbreaking, powerful artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.
We work with leading biopharma companies to accelerate and optimize drug discovery, development and commercialization. Our platform leverages both clinical trial data and real world data (RWD) to model patient response to treatment in silico. These insights enable biopharma to discover which subpopulations of patients respond, which do not and more importantly understand why, directly from the data and without bias. These models can also be used to conduct in silico clinical trials generating real world evidence of a drug’s value in the real world, both before and after launch.
We partner with innovative health plans to identify which members will respond to which drug and care management interventions at what point in time. Our platform provides a prescriptive approach allowing health plans to understand the effectiveness of specific interventions, member by member.
We work with progressive patient foundations to discover novel disease pathways and drug targets to accelerate the development of new therapeutics.
By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals to dramatically improve health outcomes and reduce the total cost of care. We have modeled over forty diseases in the areas of oncology, cardiovascular and metabolic, neurology, autoimmune and others.
We understand that in order to make precision medicine a reality, we need to discover and deliver novel insights that will cure disease and heal the healthcare system.
OUR AI PLATFORM: REFS™
REFS (Reverse Engineering Forward Simulation) uncovers the cause and effect relationships from data at scale to solve healthcare’s matching problem and make precision medicine a reality.
Speed to discovery
Our platform works by reconstructing complex diseases into computer models which allows users to simulate real world scenarios that take the guesswork out of critical decisions and increase the speed to discovery from years to months.
Transparency of results
By employing causal machine learning, our models not only deliver novel insights, they identify the underlying cause and effect relationships, crucial to understanding and treating the root cause of disease progression and patient response.
Unlimited data volume and variety
We transform and integrate millions of data points of all types – EMR, genetic, proteomic, genomic, claims, consumer, laboratory, prescription, mobile health, sociodemographic and more – revealing unforeseen relationships in a dynamic platform that continues to grow smarter over time.
Healthcare’s Most Powerful AI Solution
Understand the power of causal machine learning, why it’s different than other AI solutions and why it’s critical to transform biomedicine and healthcare. Check out video below to learn more.
GNS By The Numbers
We’re all about data points, numbers and evidence.
Complex Models Built
Data Points Modeled
Years Applying AI to Healthcare
Peer Reviewed Journal Articles & Posters
Drug Discovery and AI: An Unlikely Marriage or Perfect Partners?
by firstname.lastname@example.org (GNS Healthcare) on February 14, 2019 at 2:03 pm
The following is the first in a three-part series on the impact of AI on the product development life cycle of drugs from discovery, to clinical […]
Follow the Tumor: How Oncology R&D is Leading the Charge in AI Implementation
by email@example.com (GNS Healthcare) on February 7, 2019 at 2:03 pm
In 2017, the American Cancer Society awarded $112 million for cancer research. The National Institute of Health FY17 budget for cancer […]
Revisiting 2018 Healthcare Predictions: 5 That Got It Right
by firstname.lastname@example.org (GNS Healthcare) on January 31, 2019 at 2:03 pm
The new year has just begun and the flurry of predictions for 2019 are popping up everywhere. Healthcare thought leaders have joined in offering […]
News & Events
Colin Hill, GNS CEO and co-founder moderated panel at The Forbes Healthcare Summit, held November 29th. The panel, “How Smart Is Artificial Intelligence?” brought together industry leaders to discuss the potential of AI to change healthcare. Panelists included...read more
Colin Hill, CEO and co-founder of GNS Healthcare participated on a panel at the 14th Annual Personalized Medicine Conference, held Wednesday, November 14th. The panel, “Automating Actionable: How Artificial Intelligence is Charting a Course for Personalized Medicine...read more
GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...read more
Improving The Probability of Success: New Tools in Drug Development
How robust data and powerful AI is changing the way drugs are developed.
Why BioPharma Needs AI to Succeed
Check out our infographic to see why biopharma needs AI to succeed.